DIVI'S LABORATORIES LTD. - 532488 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Divis Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here DIVI'S LABORATORIES LTD. - 532488 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
This is to inform that the 32nd Annual General Meeting (AGM) of the Company was held on August 22, 2022 at 10.00 a.m. through Video Conferencing ('VC') / Other Audio-Visual Means ('OAVM') and the business mentioned in the Notice convening the AGM dated May 23, 2022 was duly transacted. In this regard, we hereby submit the following: 1. Summary of proceedings of the 32nd Annual General Meeting along with copy of the Chairman's speech and Managing Director's speech delivered at the AGM as Annexure - I; 2. Voting Results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure - II; 3. The Report of Scrutinizer on remote e-voting and voting at AGM (by electronic means) as Annexure - III. Please note that all the resolutions set out in the Notice of 32nd AGM were passed with requisite majority. This is for your information and records. DIVI'S LABORATORIES LTD. - 532488 - Shareholder Meeting / Postal Ballot-Outcome of AGM
This is to inform that the 32nd Annual General Meeting (AGM) of the Company was held on August 22, 2022 at 10.00 a.m. through Video Conferencing ('VC') / Other Audio-Visual Means ('OAVM') and the business mentioned in the Notice convening the AGM dated May 23, 2022 was duly transacted. In this regard, we hereby submit the following: 1. Summary of proceedings of the 32nd Annual General Meeting along with copy of the Chairman's speech and Managing Director's speech delivered at the AGM as Annexure - I; 2. Voting Results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure - II; 3. The Report of Scrutinizer on remote e-voting and voting at AGM (by electronic means) as Annexure - III. Please note that all the resolutions set out in the Notice of 32nd AGM were passed with requisite majority. This is for your information and records. DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
We hereby submit the transcript of the earnings conference call for the quarter ended June 30, 2022, held on August 12, 2022 at 14.00 Hrs IST. The transcript is also available on the website of the Company i.e. www.divislabs.com, under Investors Relations section. This is for your information and records.
Buy Divis Laboratories; target of Rs 4450: Sharekhan
Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 4450 in its research report dated August 12, 2022. DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We enclose herewith copies of newspapers publication regarding extracts of unaudited financial results of the Company for the quarter ended June 30, 2022. This notice was published on August 13, 2022 in Financial Express (English daily - All editions) and Andhra Prabha (Telugu daily - Hyderabad edition). This is for your information and records. DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and further to our intimation letter dated July 29, 2022, we hereby inform that the audio recording of the earnings call for the quarter ended June 30, 2022, held on August 12, 2022 at 14.00 Hrs IST have been uploaded on the Company's website at the following weblink: https://www.divislabs.com/wp-content/uploads/2022/08/EarningsCallAudioQ1FY23.mp3 This is for your information and records. Q1FY23 Quarterly Result Announced for Divi's Laboratories Ltd.
Pharmaceuticals firm Divi's Laboratories announced Q1FY23 Result : Divi's Laboratories has earned a total income of Rs 2343 crores for the 1st quarter of the year 2022-23 on a consolidated basis as against an income of Rs 1997 crores for the corresponding quarter of last year. Profit before Tax (PBT) for the quarter amounted to Rs 851 crores as against a PBT of Rs 814 crores for the corresponding quarter of the last year. The Company earned a Profit after Tax (PAT) of Rs 702 crores for the current quarter as against a PAT of Rs 557 crores for the corresponding quarter of the last year. Forex gain for the current quarter amounted to Rs 56 crores as against a gain of Rs 20 crores during the corresponding quarter of the last year. Result PDF
Divi's Labs Q1 results: Net profit rises 26% to 702 crore
Divis Laboratories revenue from operations rose about 15% to 2,254 crore from 1,960.6 crore YoY DIVI'S LABORATORIES LTD. - 532488 - Board Meeting Outcome for Outcome Of Board Meeting - Submission Of Unaudited Financial Results For The Quarter Ended June 30, 2022-Reg
Further to our intimation dated July 28, 2022, we would like to inform that the Board of Directors of the Company at its meeting held on Friday, August 12, 2022 has approved the Unaudited Financial Results for the quarter ended June 30, 2022. In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we are enclosing herewith the following: 1. Statement of Standalone Unaudited Financial Results for the quarter ended June 30, 2022 and Limited Review Report of the Statutory Auditors thereon. 2. Statement of Consolidated Unaudited Financial Results for the quarter ended June 30, 2022 and Limited Review Report of the Statutory Auditors thereon. 3. Press Release on the Financial Results of the Company. The Board meeting commenced at 11.00 Hrs and concluded at 12.15 Hrs